Developing a"1+X"pharmaceutical consultation model through the PDCA cycle
To improve the efficiency and precision of our pharmacy consultation services,we adopted a"1+X"model based on the PDCA(Plan-Do-Check-Act)cycle.In the initial analysis,we identified factors contributing to suboptimal consultation efficiency.Our approach included a thorough examination of our pharmacy consultation system,encompassing personnel training,consultation promotion,and the refinement of the consultation process.A standardized pharmacy consultation model was devised and continually refined,with a primary focus on infectious diseases.Subsequently,the model expanded to include various medical specialties,fostering multi-disciplinary participation.Since the implementation of the"1+X"pharmacy consultation model,spanning from 2017 to 2022,consultation numbers exhibited a consistent annual growth exceeding 50％.In 2022 alone,5044 pharmaceutical consultations were conducted,encompassing 3007 standard consultations and 96 expanded consultations across diverse departments such as neurosurgery and neurology.The adoption rate of consultation recommendations reached 89.2％,while the effectiveness of consultation treatments stood at an impressive 76.4％.This success underscored the impact of the"1+X"pharmacy consultation model on enhancing consultation outcomes.Collectively,our model,rooted in the PDCA cycle,not only served as a practical blueprint for pharmacy consultation systems in medical institutions but also provided valuable insights and a robust framework for the professional development and training of clinical pharmacists.
NETL
NSTL
万方数据
